Low-Dose Total Skin Electron Beam Therapy Combined With Mogamulizumab for Refractory Mycosis Fungoides and Sézary Syndrome

PURPOSE: Management of patients with refractory mycosis fungoides and Sézary syndrome (SS) is often challenging, as available therapies lack durable response and consistent activity across disease compartments. Combining low-dose total skin electron beam therapy (LD-TSEBT) upfront with mogamulizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Fong, Sophia, Hong, Eric K., Khodadoust, Michael S., Li, Shufeng, Hoppe, Richard T., Kim, Youn H., Hiniker, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966842/
https://www.ncbi.nlm.nih.gov/pubmed/33748543
http://dx.doi.org/10.1016/j.adro.2020.11.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966842/
https://www.ncbi.nlm.nih.gov/pubmed/33748543
http://dx.doi.org/10.1016/j.adro.2020.11.014

Ejemplares similares